Evonik, a global leader in the chemical industry, embodies its mantra—"Leading Beyond Chemistry". Established in 2007 and headquartered in Germany, this trailblazing company operates across over 100 countries. In a testament to its robust market presence, Evonik achieved sales of €14.1 billion and an adjusted EBITDA of €1.9 billion in 2025.
The company's innovation-driven approach and technical expertise span key industries: Health Care, Manufacturing, Nutrition, and Wellness Beauty. With approximately 31,000 employees, Evonik is committed to augmenting customer competitiveness through tailored solutions, consistently improving quality of life globally.
Despite its significant market impact, Evonik has no recent investment activities. This stable growth trajectory and its presence in essential industries position Evonik as a potential opportunity for investors seeking impact-driven innovations within the chemical sector.